SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dishman Pharmaceuticals & Chemicals

Dishman Pharmaceuticals & Chemicals

BSE: 532526|NSE: DISHMAN|ISIN: INE353G01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 23, 15:00
225.50
-3.3 (-1.44%)
VOLUME 59,541
LIVE
NSE
Feb 23, 15:00
225.10
-3.7 (-1.62%)
VOLUME 305,136
News on Dishman Pharmaceuticals & Chemicals
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Bull's Eye: Buy Wockhardt, HCC, Jet, Siemens, PNB, REC, JSPL 

7.56 am | 21 Feb 2017 |  Source: CNBC-TV18

Vijay Chopra of Enoch Ventures suggests buying Jet Airways with a target of Rs 400....

Buy Dishman Pharma; target of Rs 285: Systematix

2.48 pm | 17 Feb 2017 |  Source: Moneycontrol.com

Systematix is bullish on Dishman Pharma has recommended buy rating on the stock with a target price of Rs 285 in its research report dated February 14...

Sell Bharti Infratel, TCS; buy Dishman Pharma: Ashwani Gujral 

12.30 pm | 17 Feb 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com is of the view that one may sell Bharti Infratel and Tata Consultancy Services....

Dishman Pharma Q3 net profit up 13% at Rs 50.68 cr

4.44 pm | 13 Feb 2017 |  Source: PTI

Dishman Pharmaceuticals and Chemicals today reported a 13.22 percent rise in its consolidated net profit to Rs 50.68 crore for the quarter ended Decem...

Dishman Pharmaceuticals declares interim dividend

4.08 pm | 13 Feb 2017 |  Source: Moneycontrol.com

Dishman Pharmaceuticals and Chemicals has informed that a Meeting of the Board of Directors of the Company was held on February 13, 2017, has declared...

Dishman Pharma's Q3 results on February 13, 2017

4.22 pm | 04 Feb 2017 |  Source: Moneycontrol.com

Dishman Pharmaceuticals has informed that a meeting of the board of Directors of the company will be held on February 13, 2017 to consider and take on...

Bull's Eye: Buy BoI, Titan, Divis Lab, Jindal Steel, KCP, IFCI 

7.55 am | 03 Feb 2017 |  Source: CNBC-TV18

Kunal Saraogi of Equityrush recommends buying Titan Company with a target of Rs 400 and Federal Bank with a target of Rs 87....

Top buzzing midcap stocks to trade on February 2 

12.44 pm | 02 Feb 2017 |  Source: CNBC-TV18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - M&M, Tata Motors, Bajaj Auto, CCL Prodcuts, Dishman ...

Dishman Pharma receives EIR report from USFDA

11.42 am | 02 Feb 2017 |  Source: PTI

"The company's Bavla facility was successfully inspected by the USFDA in July, 2016, which was intimated to the stock exchanges on July 9, 2016. In th...

Dishman Pharma rises 4%, Bavla facility receives EIR from USFDA

9.43 am | 02 Feb 2017 |  Source: Moneycontrol.com

The company has received the Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA) for its Bavla facility on...

Dishman Pharma receives EIR from USFDA for Bavla facility

8.14 am | 02 Feb 2017 |  Source: Moneycontrol.com

Dishman Pharmaceuticals has received the Establishment Inspection Report (EIR) from the US FDA for Bavla facility on February 01, 2017. Thus, the Comp...

Stocks in news: M&M, Cipla, Apar, Sona Koyo, Marico, Tata Global 

8.00 am | 02 Feb 2017 |  Source: CNBC-TV18

Tata Motors | Mahindra & Mahindra | Cipla | Marico | Tata Global Beverage | RPG Life | Cummins India | Apar Industries | Oricon Enterprises | Teamleas...

Dishman Pharma Q2 net profit surges near two-fold to Rs 55 cr

2.58 pm | 27 Oct 2016 |  Source: PTI

The company had posted a net profit after taxes, minority interest and share of profit/(loss) of the associates of Rs 27.73 crore for the correspondin...

1 2
Quick Links for Dishman Pharmaceuticals & Chemicals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.